Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.834 USD | +0.97% | -7.33% | -41.27% |
Mar. 19 | Tranche Update on Zepp Health Corporation's Equity Buyback Plan announced on November 16, 2021. | CI |
Mar. 19 | Transcript : Zepp Health Corporation, Q4 2023 Earnings Call, Mar 18, 2024 |
Sales 2023 | 2.5B 345M | Sales 2024 * | 2.3B 318M | Capitalization | 369M 50.91M |
---|---|---|---|---|---|
Net income 2023 | -212M -29.28M | Net income 2024 * | -131M -18.09M | EV / Sales 2023 | 0.25 x |
Net cash position 2023 * | - 0 | Net cash position 2024 * | - 0 | EV / Sales 2024 * | 0.16 x |
P/E ratio 2023 |
-2.93
x | P/E ratio 2024 * |
-11.1
x | Employees | 987 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 33.95% |
Latest transcript on Zepp Health Corporation
1 day | +0.97% | ||
1 week | -7.33% | ||
Current month | -18.24% | ||
1 month | -22.06% | ||
3 months | -47.88% | ||
6 months | -22.06% | ||
Current year | -41.27% |
Managers | Title | Age | Since |
---|---|---|---|
Wang Huang
CEO | Chief Executive Officer | 48 | 13-12-26 |
Leon Cheng Deng
DFI | Director of Finance/CFO | 41 | 20-09-30 |
Mei Hui Fan
CTO | Chief Tech/Sci/R&D Officer | 45 | 21-08-18 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bing Xie
BRD | Director/Board Member | 57 | 20-11-21 |
Hong Jiang Zhang
BRD | Director/Board Member | 63 | 18-01-31 |
De Liu
BRD | Director/Board Member | 51 | 15-03-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 0.834 | +0.97% | 33,809 |
24-04-18 | 0.826 | +0.05% | 62,888 |
24-04-17 | 0.8256 | -2.87% | 72,056 |
24-04-16 | 0.85 | -5.31% | 108,660 |
24-04-15 | 0.8977 | -0.26% | 74,703 |
Delayed Quote Nyse, April 19, 2024 at 04:00 pm EDT
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-41.27% | 50.91M | |
-1.15% | 376B | |
+27.88% | 2.03B | |
-19.20% | 1.06B | |
+77.20% | 884M | |
-6.43% | 807M | |
+4.11% | 769M | |
+45.22% | 673M | |
-34.72% | 333M | |
-12.53% | 280M |
- Stock Market
- Equities
- ZEPP Stock